Synthetic Peptide Restores the Cancer-Killing Power of Macrophages (4 of 4) (IMAGE)
Caption
Model of mannose receptor CD206 derived from small angle X-ray scattering analysis. Ricin, fibronectin II, carbohydrate recognition domains 1 to 8, transmembrane, and C-terminal domains are highlighted in different colors. This material relates to a paper that appeared in the Feb. 12, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by J.M. Jaynes at Tuskegee University in Tuskegee, AL; and colleagues was titled, "Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses."
Credit
Dr. Jesse J. Jaynes, College of Agriculture, Environment and Nutrition Sciences, Integrative Biosciences Program, Tuskegee University
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content